Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsETFsIndustryCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Chimerix (CMRX) Profit Margin (2013 - 2024)

Chimerix (CMRX) profit margin from Jun 30, 2013 to Dec 31, 2024. The current Chimerix (CMRX) profit margin is -38250.00%. You can export chart.

Annual Profit Margin

Quarterly Profit Margin

Annual Profit Margin change of Chimerix (CMRX)

YearProfit MarginChange
2024-42090.48%
+64.08%
2023-25653.13%
-5139.14%
2022509.08%
-105.82%
2021-8749.49%
+979.61%
2020-810.43%
-9.87%
2019-899.20%
-6.55%
2018-962.19%
-39.13%
2017-1580.85%
+17.96%
2016-1340.18%
+22.86%
2015-1090.80%
-25.70%
2014-1468.07%
+76.06%
2013-833.87%
N/A

Comparison Chimerix (CMRX) profit margin with competitors

Chimerix (CMRX) profit margin is -38250.00%.

TickerNameProfit MarginUpside
OMEROmeros Corporation871.00%-102.28%
PRTCPureTech Health plc American Depositary Shares793.00%-102.07%
ABEOAbeona Therapeutics Inc454.90%-101.19%
CHRSCoherus Biosciences Inc397.30%-101.04%
FBIOFortress Biotech Inc193.10%-100.50%
INVAInnoviva Inc119.90%-100.31%
ZVRAZevra Therapeutics Inc101.60%-100.27%
ABUSArbutus Biopharma Corp94.73%-100.25%
SAVACassava Sciences Inc.93.68%-100.24%
GLPGGalapagos NV86.83%-100.23%
CTNMContineum Therapeutics Inc - Class A83.13%-100.22%
BDTXBlack Diamond Therapeutics Inc80.77%-100.21%
NEUPNeuphoria Therapeutics Inc75.08%-100.20%
IPSCCentury Therapeutics Inc70.13%-100.18%
FULCFulcrum Therapeutics Inc69.26%-100.18%
CVACCureVac N.V.68.44%-100.18%
PRTAProthena Corporation plc64.05%-100.17%
QTTBQ32 Bio Inc61.90%-100.16%
AVIRAtea Pharmaceuticals Inc60.95%-100.16%
ASNDAscendis Pharma A/S57.30%-100.15%
PLXProtalix BioTherapeutics Inc54.27%-100.14%
HCWBHCW Biologics Inc53.42%-100.14%
AGENAgenus Inc52.20%-100.14%
CGENCompugen Ltd48.57%-100.13%
KRYSKrystal Biotech Inc48.07%-100.13%
RPRXRoyalty Pharma plc - Class A46.73%-100.12%
XOMAPXOMA Royalty Corp45.90%-100.12%
XOMAOXOMA Royalty Corp45.90%-100.12%
AUPHAurinia Pharmaceuticals Inc44.21%-100.12%
NXTCNextcure Inc43.49%-100.11%
CPRXCatalyst Pharmaceuticals Inc42.66%-100.11%
HALOHalozyme Therapeutics Inc39.83%-100.10%
ADMAAdma Biologics Inc39.59%-100.10%
XOMAXOMA Royalty Corp36.25%-100.09%
VRTXVertex Pharmaceuticals Inc34.53%-100.09%
EXELExelixis Inc34.46%-100.09%
SLNOSoleno Therapeutics Inc33.17%-100.09%
CRMDCorMedix Inc30.29%-100.08%
TNGXTango Therapeutics Inc29.52%-100.08%
ARGXArgen X SE28.20%-100.07%
CAICaris Life Sciences Inc - Class A27.98%-100.07%
JAZZJazz Pharmaceuticals plc27.42%-100.07%
SPROSpero Therapeutics Inc24.90%-100.07%
INCYIncyte Corp23.83%-100.06%
REGNRegeneron Pharmaceuticals Inc20.17%-100.05%
NAGENiagen Bioscience Inc20.07%-100.05%
ICCCImmucell Corp18.75%-100.05%
NERVMinerva Neurosciences Inc17.79%-100.05%
ALNYAlnylam Pharmaceuticals Inc16.99%-100.04%
ENVBEnveric Biosciences Inc16.64%-100.04%
TECHBio-Techne Corp16.39%-100.04%
HRMYHarmony Biosciences Holdings Inc15.08%-100.04%
ONCBeiGene Ltd15.02%-100.04%
RIGLRigel Pharmaceuticals14.71%-100.04%
BMRNBiomarin Pharmaceutical Inc13.77%-100.04%
VXRTVaxart Inc13.20%-100.03%
IMCRImmunocore Holdings plc12.16%-100.03%
VRNAVerona Pharma Plc11.56%-100.03%
TGTXTG Therapeutics Inc9.65%-100.03%
APLSApellis Pharmaceuticals Inc6.95%-100.02%
PTGXProtagonist Therapeutics Inc6.71%-100.02%
NUVBNuvation Bio Inc - Class A6.48%-100.02%
FBIOPFortress Biotech Inc6.40%-100.02%
GMABGenmab5.92%-100.02%
SRPTSarepta Therapeutics Inc2.98%-100.01%
BMEABiomea Fusion Inc2.37%-100.01%
ACADAcadia Pharmaceuticals Inc1.36%-100.00%
FENCFennec Pharmaceuticals Inc1.33%-100.00%
FOLDAmicus Therapeutics Inc0.91%-100.00%
HOTHHoth Therapeutics Inc0.17%-100.00%
BBLGBone Biologics Corp0.02%-100.00%